PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment
- PMID: 23623495
- DOI: 10.1016/j.celrep.2013.04.007
PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment
Abstract
Dendritic cells (DCs) are essential regulators of immune responses; however, transcriptional mechanisms that establish DC lineage commitment are poorly defined. Here, we report that the PU.1 transcription factor induces specific remodeling of the higher-order chromatin structure at the interferon regulatory factor 8 (Irf8) gene to initiate DC fate choice. An Irf8 reporter mouse enabled us to pinpoint an initial progenitor stage at which DCs separate from other myeloid lineages in the bone marrow. In the absence of Irf8, this progenitor undergoes DC-to-neutrophil reprogramming, indicating that DC commitment requires an active, Irf8-dependent escape from alternative myeloid lineage potential. Mechanistically, myeloid Irf8 expression depends on high PU.1 levels, resulting in local chromosomal looping and activation of a lineage- and developmental-stage-specific cis-enhancer. These data delineate PU.1 as a concentration-dependent rheostat of myeloid lineage selection by controlling long-distance contacts between regulatory elements and suggest that specific higher-order chromatin remodeling at the Irf8 gene determines DC differentiation.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.J Biol Chem. 2011 Mar 11;286(10):7893-7904. doi: 10.1074/jbc.M110.165431. Epub 2011 Jan 7. J Biol Chem. 2011. PMID: 21216962 Free PMC article.
-
Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.J Allergy Clin Immunol. 2012 Mar;129(3):814-824.e6. doi: 10.1016/j.jaci.2011.10.019. Epub 2011 Nov 21. J Allergy Clin Immunol. 2012. PMID: 22112519
-
Dendritic cell development requires histone deacetylase activity.Eur J Immunol. 2014 Aug;44(8):2478-88. doi: 10.1002/eji.201344150. Epub 2014 Jun 16. Eur J Immunol. 2014. PMID: 24810486 Free PMC article.
-
Transcriptional control of dendritic cell development.Adv Immunol. 2013;120:239-67. doi: 10.1016/B978-0-12-417028-5.00009-0. Adv Immunol. 2013. PMID: 24070387 Review.
-
Transcriptional and Epigenetic Regulation of Innate Immune Cell Development by the Transcription Factor, Interferon Regulatory Factor-8.J Interferon Cytokine Res. 2016 Jul;36(7):433-41. doi: 10.1089/jir.2015.0138. J Interferon Cytokine Res. 2016. PMID: 27379865 Review.
Cited by
-
Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity.Front Immunol. 2020 Aug 27;11:1963. doi: 10.3389/fimmu.2020.01963. eCollection 2020. Front Immunol. 2020. PMID: 32983128 Free PMC article. Review.
-
Shared Transcriptional Control of Innate Lymphoid Cell and Dendritic Cell Development.Annu Rev Cell Dev Biol. 2019 Oct 6;35:381-406. doi: 10.1146/annurev-cellbio-100818-125403. Epub 2019 Jul 5. Annu Rev Cell Dev Biol. 2019. PMID: 31283378 Free PMC article. Review.
-
Dendritic cells in cancer immunology.Cell Mol Immunol. 2022 Jan;19(1):3-13. doi: 10.1038/s41423-021-00741-5. Epub 2021 Sep 3. Cell Mol Immunol. 2022. PMID: 34480145 Free PMC article. Review.
-
Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors.EMBO J. 2016 Nov 15;35(22):2399-2416. doi: 10.15252/embj.201693927. Epub 2016 Aug 29. EMBO J. 2016. PMID: 27572462 Free PMC article.
-
Technical Advance: Transcription factor, promoter, and enhancer utilization in human myeloid cells.J Leukoc Biol. 2015 May;97(5):985-995. doi: 10.1189/jlb.6TA1014-477RR. Epub 2015 Feb 25. J Leukoc Biol. 2015. PMID: 25717144 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases